drugset / Trial / NCT00160160

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

NCT00160160

Completed 440 enrolled Solvay Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to demonstrate the superiority of combination of eprosartan/HCTZ versus ramipril/HCTZ.

Timeline

Start
2004-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Eprosartan Small molecule
Background Hydrochlorothiazide Unknown